Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in global healthcare, announces its investment in the Sanner Group, a leading global supplier of high-quality active packaging solutions and components for the pharmaceutical, diagnostic, MedTech, and nutraceutical industries.

Headquartered in Germany and leveraging its advanced manufacturing facilities across Germany, France, Hungary, and China, Sanner has developed from a global market leader for desiccant closures and effervescent tablet packaging into a provider of customized solutions in the areas of Medical & Diagnostics, Consumer Healthcare and Pharma.

Sanner has recorded notable sales growth in recent years, with sales in 2020 increasing by more than 15% from 2019. Sanner produces more than four billion component parts each year.

Sanner develops and manufactures premium-quality plastic packaging and components for pharmaceutical applications.

Following the acquisition, GHO will work closely with existing management and the Sanner family, who remain closely involved with the business. GHO will support Sanner in accelerating growth plans through the expansion of manufacturing sites in Germany and China and developing capabilities to facilitate expansion in U.S. markets.

Leveraging Sanner’s extensive R&D and manufacturing capabilities, GHO will support management to accelerate product expansion initiatives, sales, and investment in business development to deliver margin improvements and increase capacity to drive growth.

Also, Sanner is committed to sustainability and has ambitious targets to reduce energy consumption and CO2 emissions while using materials more efficiently. The business has successfully reduced CO2 emissions by more than 40% at its Bensheim site, measured in terms of production volume since 2012. The business also plans to expand its use of bio-based plastics across its product portfolio, which contribute to climate protection by reducing CO2 emissions.

The Partners at GHO Capital, mentioned, “Backed by more than 120 years of industry experience, Sanner is a recognized market leader with a standout reputation for innovation, quality, and reliability. With our support, management are well placed to realize the shared ambition to accelerate Sanner’s growth, investing in both existing facilities and operations as well as leveraging our US expertise to identify growth opportunities.”

Jürgen Sanner, shareholder of Sanner GmbH, added, “We have been observing increasing consolidation in the market for some time now. As a medium-sized company, we must react if we want to remain successful in the long term. With GHO, we have found a strong partner that specializes in the healthcare and medtech sectors and offers us further opportunities for successful growth."

Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in global healthcare, announces its investment in the Sanner Group, a leading global supplier of high-quality active packaging solutions and components for the pharmaceutical, diagnostic, MedTech, and nutraceutical industries.

Headquartered in Germany and leveraging its advanced manufacturing facilities across Germany, France, Hungary, and China, Sanner has developed from a global market leader for desiccant closures and effervescent tablet packaging into a provider of customized solutions in the areas of Medical & Diagnostics, Consumer Healthcare and Pharma.

Sanner has recorded notable sales growth in recent years, with sales in 2020 increasing by more than 15% from 2019. Sanner produces more than four billion component parts each year.

Sanner develops and manufactures premium-quality plastic packaging and components for pharmaceutical applications.

Following the acquisition, GHO will work closely with existing management and the Sanner family, who remain closely involved with the business. GHO will support Sanner in accelerating growth plans through the expansion of manufacturing sites in Germany and China and developing capabilities to facilitate expansion in U.S. markets.

Leveraging Sanner’s extensive R&D and manufacturing capabilities, GHO will support management to accelerate product expansion initiatives, sales, and investment in business development to deliver margin improvements and increase capacity to drive growth.

Also, Sanner is committed to sustainability and has ambitious targets to reduce energy consumption and CO2 emissions while using materials more efficiently. The business has successfully reduced CO2 emissions by more than 40% at its Bensheim site, measured in terms of production volume since 2012. The business also plans to expand its use of bio-based plastics across its product portfolio, which contribute to climate protection by reducing CO2 emissions.

The Partners at GHO Capital, mentioned, “Backed by more than 120 years of industry experience, Sanner is a recognized market leader with a standout reputation for innovation, quality, and reliability. With our support, management are well placed to realize the shared ambition to accelerate Sanner’s growth, investing in both existing facilities and operations as well as leveraging our US expertise to identify growth opportunities.”

Jürgen Sanner, shareholder of Sanner GmbH, added, “We have been observing increasing consolidation in the market for some time now. As a medium-sized company, we must react if we want to remain successful in the long term. With GHO, we have found a strong partner that specializes in the healthcare and medtech sectors and offers us further opportunities for successful growth."